Mark Kingdon just issued a filing suggesting it has sold all of its Dipexium Pharmaceuticals, Inc.

Mark Kingdon recently filed a "Statement of acquisition of beneficial ownership by individuals" with the SEC in which it appears to no longer have any shares of Dipexium Pharmaceuticals, Inc..Previously it appears as though Mark Kingdon owned as many as 975,099 shares. To see the most recent portfolio of Mark Kingdon see here.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Auto Refresh

Feedback